Strauss M E, Barrick E D, Bannister R M
Monsanto Company, St Louis, Missouri.
Br J Ind Med. 1993 Oct;50(10):888-93. doi: 10.1136/oem.50.10.888.
Mortality trends for 1059 production workers at a rubber chemicals plant in Nitro, West Virginia were examined to find whether they had increased mortality from cancer associated with exposure to 2-mercaptobenzothiazole (MBT). This chemical and its derivatives are vulcanising agents that have been manufactured at the plant since 1935. Analyses were conducted on MBT exposed employees by cumulative exposure and time since first exposure, and were also stratified by past assignment to p-aminobiphenyl (PAB) related departments; PAB is a potent bladder carcinogen that was used at the plant between 1935 and 1955. There was an excess of bladder cancer in MBT workers who had PAB related assignments (standardised mortality ratio (SMR) = 3200, 95% confidence interval (95% CI) 1286-6593). In employees without a job assignment with exposure to PAB, there were no associations between exposure to MBT and increased rates of most malignant neoplasms. The SMR for bladder cancer was increased based on three deaths (SMR = 455, 95% CI 94-1328), although these results were too few to evaluate trends by cumulative exposure category. The possibility of confounding by PAB for exposures for jobs that covered all areas of the plant for these three cases must be considered in the light of the potency of PAB as a bladder carcinogen. There were no deaths from bladder cancer among MBT workers hired after the end of manufacture and use of PAB, but the expected number of deaths was only 0.03.
对西弗吉尼亚州尼托一家橡胶化学品厂的1059名生产工人的死亡率趋势进行了调查,以确定他们是否因接触2-巯基苯并噻唑(MBT)而导致癌症死亡率增加。这种化学品及其衍生物是硫化剂,自1935年以来该厂一直在生产。对接触MBT的员工按累积接触量和首次接触后的时间进行了分析,并按过去是否被分配到与对氨基联苯(PAB)相关的部门进行了分层;PAB是一种强效膀胱致癌物,该厂在1935年至1955年间使用过。在有PAB相关工作任务的MBT工人中,膀胱癌发病率过高(标准化死亡比(SMR)=3200,95%置信区间(95%CI)1286-6593)。在没有接触PAB工作任务的员工中,接触MBT与大多数恶性肿瘤发病率增加之间没有关联。基于三例死亡病例,膀胱癌的SMR有所增加(SMR=455,95%CI 94-1328),尽管这些结果数量太少,无法按累积接触类别评估趋势。鉴于PAB作为膀胱致癌物的效力,必须考虑这三例涉及该厂所有区域工作接触的病例中PAB造成混杂的可能性。在停止生产和使用PAB后雇佣的MBT工人中没有膀胱癌死亡病例,但预期死亡人数仅为0.03。